Infectious Disease drugs
19 results
Baxdela (delafloxacin meglumine)
(delafloxacin meglumine)Melinta Therapeutics, LLC
Usage: BAXDELA is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults caused by specific susceptible bacteria, including MRSA and MSSA. It should be used judiciously to prevent drug resistance and based on culture and susceptibility data when available.
Dalvance (dalbavancin)
(Dalbavancin)Allergan, Inc.
Usage: DALVANCE® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatric patients caused by specific susceptible Gram-positive bacteria, including Staphylococcus aureus and Enterococcus faecalis. Its use aims to reduce drug-resistant bacteria development.
Exelderm (sulconazole nitrate)
(Sulconazole Nitrate)Journey Medical Corporation
Usage: EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is indicated for treating tinea pedis (athlete's foot), tinea cruris, and tinea corporis caused by specific fungi, as well as tinea versicolor. Efficacy against Microsporum canis was studied in a limited number of infections.
Filsuvez (birch triterpenes)
(birch triterpenes)Amryt Pharmaceuticals DAC
Usage: FILSUVEZ is indicated for treating wounds related to dystrophic and junctional epidermolysis bullosa (EB) in adults and pediatric patients aged 6 months and older.
Flebogamma (immune globulin (human))
(Immune Globulin (Human))GRIFOLS USA, LLC
Usage: Flebogamma 5% DIF is indicated for the treatment of primary immunodeficiency in adults and pediatric patients aged 2 years and older, including conditions like common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.
Gamastan (immune globulin (human))
(immune globulin (human))GRIFOLS USA, LLC
Usage: GAMASTAN is a human immune globulin indicated for prophylaxis against hepatitis A after exposure, prevention/modification of measles in susceptible individuals post-exposure, modification of varicella, and rubella in exposed women who won't consider abortion. It is not indicated for hepatitis B prophylaxis or routine vaccinations.
Jublia (efinaconazole)
(efinaconazole)Bausch Health US LLC
Usage: JUBLIA (efinaconazole) topical solution, 10% is indicated for the topical treatment of onychomycosis of the toenails caused by Trichophyton rubrum and Trichophyton mentagrophytes.
Kimyrsa (oritavancin diphosphate)
(oritavancin diphosphate)Melinta Therapeutics, LLC
Usage: KIMYRSA® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults caused by specific Gram-positive bacteria, including methicillin-susceptible and resistant Staphylococcus aureus, as well as other susceptible Streptococcus and Enterococcus species. It should be used judiciously to prevent antibiotic resistance.
Luzu (luliconazole)
(LULICONAZOLE)Bausch Health US, LLC
Usage: LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis, specifically caused by Trichophyton rubrum and Epidermophyton floccosum.
Nuzyra (omadacycline)
(omadacycline)Paratek Pharmaceuticals, Inc.
Usage: NUZYRA is indicated for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by specific susceptible bacteria. It should be used to treat infections proven or suspected to be due to these organisms to reduce drug resistance.